摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

二季戊四醇六(3-巯基丙酸酯) | 25359-71-1

中文名称
二季戊四醇六(3-巯基丙酸酯)
中文别名
肌醇六(巯基丙酸酯)
英文名称
dipentaerythritol hexakis(3-mercaptopropionate)
英文别名
dipentaerythrytol hexakis(3-mercaptopropionate);dipentaerythritolhexakis(3-mercaptopropionate);dipentaerythritol hexa(3-mercaptopropionate);DPMP;dipentaerythritol hexakis(3-mercapto-propionate);[3-(3-sulfanylpropanoyloxy)-2-[[3-(3-sulfanylpropanoyloxy)-2,2-bis(3-sulfanylpropanoyloxymethyl)propoxy]methyl]-2-(3-sulfanylpropanoyloxymethyl)propyl] 3-sulfanylpropanoate
二季戊四醇六(3-巯基丙酸酯)化学式
CAS
25359-71-1
化学式
C28H46O13S6
mdl
——
分子量
783.061
InChiKey
YAAUVJUJVBJRSQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    828.8±65.0 °C(Predicted)
  • 密度:
    1.299±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1
  • 重原子数:
    47
  • 可旋转键数:
    34
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.79
  • 拓扑面积:
    173
  • 氢给体数:
    6
  • 氢受体数:
    19

SDS

SDS:586c1a3dc1ef97b78ce8611907586674
查看

反应信息

  • 作为反应物:
    描述:
    衣康酸二季戊四醇六(3-巯基丙酸酯)N-乙基-2-吡咯烷酮 作用下, 反应 3.0h, 生成
    参考文献:
    名称:
    착색 조성물, 경화막, 컬러 필터, 컬러 필터의 제조 방법, 고체 촬상 소자, 및 화상 표시 장치
    摘要:
    提供含有改性染料和使用改性染料的硬化膜、彩色滤光片、彩色滤光片的制备方法、固态成像元件和图像显示装置。包含以下一般式(I)中的染料和(B)中的聚合物化合物的染色组合物。在一般式(I)中,Q代表(m+n)的连接基,R代表取代基,D代表染料残基。m表示0~6的整数,n表示2~8的整数,(m+n)表示2~8的整数。当m大于等于2时,多个R可以互不相同,当n大于等于2时,多个D可以互不相同。一般式(I)为(R)-Q-(D)。
    公开号:
    KR20160014699A
  • 作为产物:
    描述:
    双季戊四醇3-巯基丙酸硫酸 作用下, 以 甲苯 为溶剂, 反应 48.0h, 以58%的产率得到二季戊四醇六(3-巯基丙酸酯)
    参考文献:
    名称:
    Organic thiol metal-free stabilizers and plasticizers for halogen-containing polymers
    摘要:
    本文描述了基于对羟基甲苯和二对羟基甲苯的有机硫醇化合物。更具体地说,本发明的化合物是对羟基甲苯和二对羟基甲苯的混合酯,具有至少一个巯基和最好是多个巯基,以及至少一个非巯基含有基团。这些有机硫醇化合物被用于增塑和/或热稳定含卤素聚合物组合物,特别是聚氯乙烯组合物。这些组合物基本上不含或不含金属基稳定剂、路易斯酸和萜类物质。本发明的化合物在通常容易恶化和变色的聚合物中得到理想应用,这种恶化和变色可能发生在聚合物加工过程中或聚合物暴露于某些环境中,并且令人惊讶地还可作为优秀的增塑剂。
    公开号:
    US20050049307A1
点击查看最新优质反应信息

文献信息

  • BIODEGRADABLE HYBRID POLYMERS USABLE IN MEDICAL TECHNOLOGY OR IN BIOLOGY, STARTING SILANES THEREFOR, AND PREPARATION PROCESS THEREFOR AND USES THEREOF
    申请人:Fraunhofer-Gesellschaft Zur Forderung der Angewandten Forschung E.V.
    公开号:US20170313726A1
    公开(公告)日:2017-11-02
    The invention relates to a silane or silane mixture obtainable by reacting a hydrolysable silane of the formula (A): SiR4 in which R is a hydrolytically condensable group or hydroxyl with a compound R*(OH)x where x is 1, 2, 3 or greater 3, where R* has a straight-chain or branched hydrocarbon skeleton which, according to the number x, is monovalent, divalent, trivalent or multivalent, and has a hydrocarbonaceous chain interrupted by at least two —C(O)O— groups, wherein there are a maximum of 8 successive carbon atoms in the individual hydrocarbon units formed by interruptions within this chain and the, or in the case of branched structures at least one, end of the hydrocarbonaceous chain at the opposite end to the sole hydroxyl group or one of the hydroxyl groups bears an organically polymerizable group, wherein the alcohol is otherwise unsubstituted or has further substituents. The invention further relates to an organically modified silica polycondensate formed as a result of hydrolytic condensation of the silane or silane mixture and optionally a subsequent organic polymerization of the organically polymerizable groups, with optional addition of an organic, at least difunctional compound to the silica polycondensate prior to the organic polymerization.
    该发明涉及一种硅烷或硅烷混合物,其可通过将具有以下式(A)的可水解硅烷与化合物R*(OH)x反应而得到:SiR4,其中R是一个可水解缩聚基团或羟基,化合物R*具有直链或支链烃骨架,根据数目x,该骨架是一价、二价、三价或多价的,并且具有至少两个—C(O)O—基团中断的烃链,其中在该链内由中断形成的各个烃单元中最多有8个连续的碳原子,或者在支链结构的情况下,至少有一个烃链的末端,与唯一的羟基或其中一个羟基相对的末端具有一个有机聚合基团,其中醇在其他方面未被取代或具有进一步的取代基。该发明还涉及一种有机改性的二氧化硅缩聚物,其是由硅烷或硅烷混合物的水解缩聚以及有机聚合基团的随后有机聚合形成的,有机聚合之前在有机聚合之前向二氧化硅缩聚物中添加有机的至少二官能化合物。
  • Organic thiol metal-free stabilizers and plasticizers for halogen-containing polymers
    申请人:Starnes Herbert William
    公开号:US20050049307A1
    公开(公告)日:2005-03-03
    Organic thiol compounds based on pentaerythritol and dipentaerythritol are described herein. More specifically, the compounds of the present invention are mixed esters of pentaerythritol and dipentaerythritol having at least one sulfhydryl group and preferably a plurality of sulfhydryl groups as well as at least one non-thiol-containing group. The organic thiol compounds are utilized to plasticize and/or heat stabilize halogen-containing polymer compositions especially poly(vinyl chloride) compositions. The compositions are substantially free or free of metal-based stabilizers, Lewis acids and terpenes. The compounds of the present invention are ideally utilized in polymers normally susceptible to deterioration and color change which can occur during processing of the polymer or exposure of the polymer to certain environments and surprisingly also serve as excellent plasticizers.
    本文描述了基于对羟基甲苯和二对羟基甲苯的有机硫醇化合物。更具体地说,本发明的化合物是对羟基甲苯和二对羟基甲苯的混合酯,具有至少一个巯基和最好是多个巯基,以及至少一个非巯基含有基团。这些有机硫醇化合物被用于增塑和/或热稳定含卤素聚合物组合物,特别是聚氯乙烯组合物。这些组合物基本上不含或不含金属基稳定剂、路易斯酸和萜类物质。本发明的化合物在通常容易恶化和变色的聚合物中得到理想应用,这种恶化和变色可能发生在聚合物加工过程中或聚合物暴露于某些环境中,并且令人惊讶地还可作为优秀的增塑剂。
  • [DE] VERWENDUNG VON SUBSTITUIERTEN 2-PHENYLBENZIMIDAZOLEN ALS ARZNEIMITTEL<br/>[EN] USE OF SUBSTITUTED 2-PHENYLBENZIMIDAZOLES AS MEDICAMENTS<br/>[FR] UTILISATION DE 2-PHENYLBENZIMIDAZOLES SUBSTITUES EN TANT QUE MEDICAMENTS
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2004062663A1
    公开(公告)日:2004-07-29
    Die vorliegende Erfindung betrifft die Verwendung eines substituierten 2-Phenylbenzimidazols der Formel (I), worin R1, R2, R3, R4, R5 und m die in den Ansprüchen angegebenen Bedeutungen aufweisen, für die Herstellung eines Medikamentes zur Behandlung oder Vorbeugung von Krankheiten, bei denen Glucagon Rezeptoren beteiligt sind, sowie neue Verbindungen der Formel (I), worin R1 ein Dehydroabietyl-Rest der Formel (II) ist.
    这项发明涉及使用式(I)的取代2-苯基苯并咪唑,其中R1、R2、R3、R4、R5和m具有权利要求中所述的含义,用于制备一种药物,用于治疗或预防涉及胰高血糖素受体的疾病,以及式(I)中R1为式(II)的脱氢松香烯基团的新化合物。
  • BORATE-BASED BASE GENERATOR, AND BASE-REACTIVE COMPOSITION COMPRISING SUCH BASE GENERATOR
    申请人:WAKO PURE CHEMICAL INDUSTRIES, LTD.
    公开号:US20160340374A1
    公开(公告)日:2016-11-24
    An object of the present invention is to provide a compound which is capable of attaining a composition having high storage stability without reacting with a base-reactive compound, even in the case of storage for a long period of time in a mixed state with the base-reactive compound, such as an epoxy-based compound, as well as capable of generating a strong base (guanidines, biguanides, phosphazenes or phosphoniums) by irradiation of light (active energy rays) or heating; a base generator comprising the compound; and a base-reactive composition comprising the base generator and the base-reactive compound. The present invention relates to the compound represented by the general formula (A); the base generator comprising the compound; and the base-reactive composition comprising the base generator and the base-reactive compound. (wherein R 1 represents an alkyl group; an arylalkynyl group which may be substituted with a halogen atom, an alkyl group, an alkoxy group, or an alkylthio group; an alkenyl group; a 2-furylethynyl group; a 2-thiophenylethynyl group; or a 2,6-dithianyl group; R 2 to R 4 each independently represent an alkyl group; an arylalkynyl group which may be substituted with a halogen atom, an alkyl group, an alkoxy group, or an alkylthio group; the aryl group which may be substituted with a halogen atom, an alkyl group, an alkoxy group, or an alkylthio group; a furanyl group; a thienyl group; or an N-alkyl-substituted pyrrolyl group; Z + represents an ammonium cation having a guanidinium group, a biguanidium group or a phosphazenium group, or a phosphonium cation.)
    本发明的目的是提供一种化合物,能够在与碱反应性化合物混合状态长时间存储的情况下,仍能获得具有高储存稳定性的组合物,而不与碱反应性化合物发生反应,同时还能通过光照(活性能量射线)或加热产生强碱(胍胺、双胍胺、磷氮烷或磷銨);包括该化合物的碱发生器;以及包括该碱发生器和碱反应性化合物的碱反应性组合物。本发明涉及由通式(A)表示的化合物;包括该化合物的碱发生器;以及包括该碱发生器和碱反应性化合物的碱反应性组合物。(其中R1代表烷基;可能被卤素原子、烷基、烷氧基或烷硫基取代的芳基炔基;烯基;2-呋喃基炔基;2-噻吩基炔基;或2,6-二硫基基;R2到R4各自独立地代表烷基;可能被卤素原子、烷基、烷氧基或烷硫基取代的芳基炔基;可能被卤素原子、烷基、烷氧基或烷硫基取代的芳基;呋喃基;噻吩基;或N-烷基取代的吡咯基;Z+代表具有胍胺基团、双胍胺基团或磷氮烷基团的铵阳离子,或磷銨阳离子。)
  • ACID-RESISTANT BASE AND/OR RADICAL GENERATOR, AND CURABLE RESIN COMPOSITION CONTAINING SAID BASE AND/OR RADICAL GENERATOR
    申请人:WAKO PURE CHEMICAL INDUSTRIES, LTD.
    公开号:US20190002403A1
    公开(公告)日:2019-01-03
    The present invention relates to a compound represented by the general formula (A), a base- and/or radical-generating agent comprising the compound, and so on. In the formula, four pieces of R 1 each independently represents a hydrogen atom or a fluorine atom; four pieces of R 2 each independently represent a fluorine atom or a trifluoromethyl group; R 3 , R 6 , R 7 and R 10 each independently represent a hydrogen atom or an alkyl group having 1 to 12 carbon atoms; R 4 and R 5 each independently represent a hydrogen atom or an alkyl group having 1 to 12 carbon atoms, or R 4 and R 5 are bonded to each other to represent an alkylene group having 2 to 4 carbon atoms; and R 8 and R 9 each independently represent a hydrogen atom, an alkyl group having 1 to 12 carbon atoms, or an aryl group having 6 to 14 carbon atoms and optionally having a substituent selected from the group consisting of an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, an alkylthio group having 1 to 6 carbon atoms, a dialkylamino group having 2 to 12 carbon atoms, a halogen atom, and a nitro group, or R 8 and R 9 are bonded to each other to represent an alkylene group having 2 to 4 carbon atoms; provided that two or three of the eight groups R 3 to R 10 are each a hydrogen atom, and, in a case where two of the eight groups are each a hydrogen atom, then three to six of the remaining groups are each an alkyl group having 1 to 12 carbon atoms, and, in a case where three of the eight groups are each a hydrogen atom, then four or five of the remaining groups are each an alkyl group having 1 to 12 carbon atoms.
    本发明涉及一种由通式(A)表示的化合物,包括该化合物的生成碱基和/或基团产生剂等。在该式中,四个R1分别独立表示氢原子或氟原子;四个R2分别独立表示氟原子或三氟甲基基团;R3、R6、R7和R10分别独立表示氢原子或具有1至12个碳原子的烷基基团;R4和R5分别独立表示氢原子或具有1至12个碳原子的烷基基团,或者R4和R5相互连接表示具有2至4个碳原子的亚烷基基团;R8和R9分别独立表示氢原子、具有1至12个碳原子的烷基基团或具有6至14个碳原子且可选地具有选自包括具有1至6个碳原子的烷基基团、具有1至6个碳原子的烷氧基团、具有1至6个碳原子的烷硫基团、具有2至12个碳原子的二烷基氨基团、卤素原子和硝基基团的取代基的芳基团,或者R8和R9相互连接表示具有2至4个碳原子的亚烷基基团;前提是八个基团R3至R10中的两个或三个分别是氢原子,并且在其中两个基团分别是氢原子的情况下,其余基团中的三到六个分别是具有1至12个碳原子的烷基基团,而在其中三个基团分别是氢原子的情况下,其余基团中的四个或五个分别是具有1至12个碳原子的烷基基团。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物